Sowell Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $701K | Sell |
8,454
-9
| -0.1% | -$746 | 0.03% | 516 |
|
|
2025
Q1 | $686K | Buy |
+8,463
| New | +$686K | 0.03% | 506 |
|
|
2024
Q4 | – | Sell |
-12,291
| Closed | -$1.21M | – | 619 |
|
|
2024
Q3 | $1.21M | Sell |
12,291
-3,439
| -22% | -$340K | 0.06% | 313 |
|
|
2024
Q2 | $1.46M | Sell |
15,730
-26
| -0.2% | -$2.41K | 0.07% | 281 |
|
|
2024
Q1 | $1.5M | Sell |
15,756
-1,235
| -7% | -$117K | 0.07% | 282 |
|
|
2023
Q4 | $1.52M | Sell |
16,991
-1,389
| -8% | -$124K | 0.08% | 263 |
|
|
2023
Q3 | $1.34M | Buy |
18,380
+131
| +0.7% | +$9.57K | 0.08% | 260 |
|
|
2023
Q2 | $1.52M | Buy |
18,249
+6,346
| +53% | +$528K | 0.08% | 266 |
|
|
2023
Q1 | $907K | Sell |
11,903
-243
| -2% | -$18.5K | 0.07% | 312 |
|
|
2022
Q4 | $1.01M | Buy |
+12,146
| New | +$1.01M | 0.07% | 314 |
|
|
2022
Q1 | – | Sell |
-15,318
| Closed | -$1.72M | – | 527 |
|
|
2021
Q4 | $1.72M | Buy |
15,318
+35
| +0.2% | +$3.92K | 0.1% | 224 |
|
|
2021
Q3 | $1.92M | Sell |
15,283
-13,473
| -47% | -$1.69M | 0.13% | 183 |
|
|
2021
Q2 | $3.89M | Buy |
28,756
+988
| +4% | +$134K | 0.26% | 108 |
|
|
2021
Q1 | $3.49M | Buy |
27,768
+11,263
| +68% | +$1.42M | 0.12% | 163 |
|
|
2020
Q4 | $2.32M | Buy |
16,505
+1,333
| +9% | +$188K | 0.1% | 186 |
|
|
2020
Q3 | $1.69M | Sell |
15,172
-8,651
| -36% | -$964K | 0.08% | 204 |
|
|
2020
Q2 | $2.67M | Buy |
23,823
+6,363
| +36% | +$712K | 0.15% | 133 |
|
|
2020
Q1 | $1.35M | Sell |
17,460
-4,970
| -22% | -$385K | 0.1% | 203 |
|
|
2019
Q4 | $2.13M | Buy |
22,430
+7,581
| +51% | +$721K | 0.16% | 137 |
|
|
2019
Q3 | $1.13M | Buy |
+14,849
| New | +$1.13M | 0.09% | 227 |
|
|
2019
Q1 | $1.34M | Buy |
14,759
+762
| +5% | +$69K | 0.15% | 152 |
|
|
2018
Q4 | $1M | Buy |
+13,997
| New | +$1M | 0.14% | 159 |
|